Target intelligence / Profile preview

Bacterial topoisomerase IV–DNA cleavage complex (Topo IV–DNA complex)

Target
Topo IV–DNA complex
Molecular classification
Enzyme, Type II topoisomerase, Isomerase
01

Overview

Bacterial topoisomerase IV is an essential type II topoisomerase enzyme that plays a critical role in bacterial cell division by decatenating interlinked daughter chromosomes following DNA replication (PubMed: 15659347). The enzyme is a heterotetramer consisting of two ParC subunits, which handle DNA cleavage and ligation, and two ParE subunits, which provide energy through ATP hydrolysis (UniProt: P0AFI2, P0AFI6). The 'cleavage complex' is a transient catalytic intermediate where the enzyme creates a double-strand break in the DNA to allow the passage of another DNA duplex. This specific state is the primary therapeutic target for fluoroquinolone antibiotics, which bind to the enzyme-DNA interface and stabilize the complex (PubMed: 20533938). By preventing the religation of the DNA strands, these drugs effectively convert the enzyme into a cellular toxin that induces permanent DNA damage and rapid bacterial cell death (StatPearls: NBK547703). Topoisomerase IV is particularly important as a target in Gram-positive bacteria, though it is also a secondary target in many Gram-negative species.

Other names
DNA topoisomerase IVTopo IVParC-ParE complexType II topoisomeraseGrlA-GrlB complex
02

Mechanism of action

Stabilization of the covalent enzyme-DNA cleavage complex, which prevents DNA religation and leads to lethal double-strand breaks.

03

Biological functions

DNA decatenationChromosome segregationDNA relaxationDNA replication
04

Disease associations

Infection
05

Safety considerations

Tendonitis and tendon rupturePeripheral neuropathyCentral nervous system effects (seizures, hallucinations)QT interval prolongationDevelopment of antibiotic resistance (QRDR mutations)
06

Interacting drugs

Ciprofloxacin

7 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)ParC gene mutationsParE gene mutationsBacterial DNA fragmentation

Beyond the preview

Go deeper on Bacterial topoisomerase IV–DNA cleavage complex (Topo IV–DNA complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial topoisomerase IV–DNA cleavage complex (Topo IV–DNA complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call